Effect of remimazolam on working memory in brain tumor patients
Part of Brain & nervous system, Cancer clinical trials.
This trial tests how a sedative drug called remimazolam affects working memory (the ability to hold and use information) in people with a type of brain tumor called glioma. It uses brain wave recordings to understand the drug's effect, which could help improve anesthesia care for brain surgery patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- You must be a native Chinese speaker and right-handed.
- You must have normal or corrected vision (with glasses or contacts).
- If you have a glioma, it must be a single tumor on one side of the brain, in the upper part, and you must be scheduled for surgery with anesthesia.
- You must be generally healthy (ASA I-II) and have no serious mental or neurological conditions.
- You must not be allergic to remimazolam or have a history of drug or alcohol abuse.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether the anesthesia medicine remimazolam can improve recovery and longer-term outcomes after surgery for early-stage bladder cancer. If you are having a bladder tumor procedure through the urethra, this study may help doctors understand whether this anesthesia choice matters for prognosis.
This trial tests a sedative called remimazolam besylate in patients who need a breathing tube and light sedation after non-cardiac surgery. The goal is to see if it works well and is safe.
This study looks at how different anesthetics change brain connections during surgery for a type of brain tumor called glioma. It may help doctors choose the best anesthesia for your surgery.
This study tests a medicine called remimazolam to see if it reduces confusion and agitation (emergence delirium) when children wake up from brain surgery. It may help your child have a smoother recovery.
This study uses brain scans to see how a new sedative called remimazolam affects the brain in healthy adults. It will help researchers understand the drug's effects and ensure it's safe.
This trial compares two ways of giving the sedative remimazolam during brain bypass surgery. It looks at which method uses less medicine. If you are having this surgery, you may be able to join.
Hear when a new Remimazolam Mild Sedation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.